A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES)
Clinical trial NCT05603754 · COMPLETED
Trial details
- NCT number
- NCT05603754
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-18
- Primary completion
- 2024-02-20
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.